小分子肝素治疗短暂性脑缺血发作价值分析  

Analysis of treatment with small molecule heparin in transient ischemic attack

作　　者：刘蕾[1] 刘恒新[1] 

机构地区：[1]解放军第八十八医院,山东泰安271000

出　　处：《中国当代医药》2011年第36期68-69,共2页China Modern Medicine

摘　　要：目的:分析小分子肝素治疗短暂性脑缺血发作的临床价值。方法:选择44例患者使用小分子肝素治疗,并与单纯使用肠溶性阿司匹林治疗患者比较,观察治疗后患者的临床疗效以及治疗期间出现的不良反应和并发症。结果:观察组治愈例数明显多于对照组(P<0.05),观察组治疗后有复发但临床症状缓解和进展为脑梗死的概率明显小于对照组(P<0.05),两组均未出现上消化道出血、泌尿系统出血、鼻出血等严重出血性并发症。结论:低分子肝素能有效抑制短暂性脑缺血发作,其临床疗效显著,不良反应少,是一种安全有效的治疗方法。Objective： To analyze the value of the treatment with small molecule heparin in transient ischemic attack. Methods： Forty-four patients with small-molecule heparin, and used the enteric-coated aspirin alone in patients, the clinical efficacy and adverse reactions were compared. Results： The number of cases in the observation grnup cured were significantly more than the control group （P〈0.05）, but relapse after treatment and clinical remission rate of progression to cerebral infarction was significantly less than the control group （P〈0.05）, two groups had no gastrointestinal bleeding, urinary tract bleeding, nose bleeding and other serious bleeding complications. Conclusion： Small molecular heparin can inhibit the transient ischemic attack, its clinical effect is significant, so it is a safe and effective treatment.

关 键 词：小分子肝素 短暂性脑缺血发作 临床疗效 并发症 

分 类 号：R743.31[医药卫生—神经病学与精神病学]